国色A片V一区二区三区下,把女人弄爽特黄a大片,扒开粉嫩小泬直接进视频,久久久久 亚洲 无码 AV 专区

您好,歡迎光臨上海雅吉生物商城!
工作時(shí)間:9:00-18:00
全國服務(wù)熱線:021-34661276

Brilliant Violet 421™ anti-human CD127 (IL-7

訂購數(shù)量:
規(guī)格
價(jià)格庫存
訂購熱線:021-34661276
我要詢價(jià)
  • 商品詳情
  • 售后服務(wù)
  • 相關(guān)文獻(xiàn)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Recombinant human CD127
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported (for the relevant formats) application: proteogenomics1.

Additional Product Notes

View more applications data using this product to resolve dim populations, determine staining index, and to detect CLPs in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  2. Fuhrman C, et al. 2015. J Immunol. 195: 145 - 155. PubMed
  3. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  4. Cuadrado E, et al. 2018. Immunity. 48:1046. PubMed
  5. Trabanelli S, et al. 2017. Nat Commun. 10.1038/s41467-017-00678-2. PubMed
  6. Witkowski M, et al. 2021. Nature. 600:295. PubMed
  7. Causi E, et al. 2015. PLoS One. 10: 0136717. PubMed
  8. Ahmed R, et al. 2020. Cell Rep. 33:108501. PubMed
  9. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  10. de Jonge K et al. 2019. Scientific reports. 9(1):4487 . PubMed
  11. Kim DH, et al. 2021. eLife. 10:00. PubMed
  12. Eller MA, et al. 2016. J Virol. 90: 4005-4016. PubMed
  13. Grove K, et al. 2016. PLoS One. 11: 0145961. PubMed
  14. Judge CJ, et al. 2017. J Leukoc Biol. 102:171. PubMed
  15. Tardif V, et al. 2019. Nat Commun. 10:823. PubMed
  16. Imai Y, et al. 2021. JID Innov. 1:100003. PubMed
  17. Rajamanickam V, et al. 2021. Cancer Immunol Res. 9:602. PubMed
  18. Gyurdieva A, et al. 2022. Nat Commun. 13:5296. PubMed
  19. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  20. Platten M, et al. 2021. Nature. 592:463. PubMed
  21. Damele L, et al. 2021. Cancers (Basel). 13:. PubMed
  22. Pasciuto E, et al. 2020. Cell. 182:625. PubMed
  23. Kato M, et al. 2021. PLoS One. 16:e0252116. PubMed
  24. Kimura K, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e210. PubMed
  25. Collins PL et al. 2018. Cell. 176(1-2):348-360 . PubMed
  26. Xu Y, et al. 2013. J Immunol Methods. 394:73. PubMed
  27. Burke MT, et al. 2017. Transplant Direct. 3:e171. PubMed
  28. Xu Y, et al. 2013. J Virol. 87:3760. PubMed
  29. Willmann K, et al. 2014. Nat Commun. 5:5360. PubMed
  30. Crump NT, et al. 2021. Cell Reports. 35(6):109101. PubMed
  31. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  32. Lev A, et al. 2019. Front Immunol. 1.577777778. PubMed
  33. O'Connor MH, et al. 2021. Commun Biol. 4:563. PubMed
  34. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  35. Zou F, et al. 2019. Nat Commun. 10:4109. PubMed
  36. Vanoni G, et al. 2021. eLife. 10:00. PubMed
  37. Kasatskaya SA, et al. 2020. Elife. :9. PubMed
  38. Gonzalez-Figueroa P, et al. 2021. Cell. 184(7):1775-1789.e19. PubMed
RRID
AB_10898326 (BioLegend Cat. No. 351309) AB_10960140 (BioLegend Cat. No. 351310)

Antigen Details

Structure
Type I transmembrane glycoprotein, associates with CD132, 60-90 kD
Distribution

Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells

Function
T cell and immature B cell proliferation and development
Ligand/Receptor
IL-7
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
2. He YW and Malek TR. 1998. Crit. Rev. Immunol. 18:503.
3. Huster KM, et al. 2004. P. Natl. Acad. Sci. USA 101:5610.
4. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.
5. Morrissey PJ, et al. 1989. J. Exp. Med. 169:707.
6. Liu W, et al. 2006. J. Exp. Med. 203:1701.

Gene ID
3575 View all products for this Gene ID
UniProt
View information about CD127 on UniProt.org
我要詢價(jià)
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會被公開)
*內(nèi)容:


微信客服
掃一掃立即咨詢


微信客服
掃一掃立即咨詢

銷售電話:

021-34661275

021-34661276

15301693058